C4 Therapeutics, Inc. - COM STK (CCCC)

Q4 2020 13F Holders as of 12/31/2020

Type / Class
Equity / COM STK
Number of holders
75
Total Shares
22.7M
Shares change
+22M
Total reported value, excl. options
$744M
Value change
+$719M
Put/Call ratio
0
Number of buys
70
Number of sells
0
Price
$33.13
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.